Cancer in dogs is diagnosed through a combination of physical examination, tissue sampling, blood work, and imaging. No single test confirms every type of cancer. Instead, your veterinarian builds a picture by layering different diagnostic tools, starting with the simplest and moving toward more detailed tests as needed. The process typically begins when a lump is found during a routine exam or when a dog develops unexplained symptoms like weight loss, lethargy, or persistent lameness.
The Physical Exam: Where It Starts
Most tumors first show up as a mass or lump discovered during a physical examination or on an imaging test. Your vet will assess the size and appearance of any mass, check whether it moves freely or is fixed to deeper tissues, and palpate the nearby lymph nodes. A firm, fast-growing, or irregularly shaped lump raises more concern than a soft, slow-growing one, but many non-cancerous conditions look identical to tumors on the surface.
Lymph node evaluation is a key part of the initial exam, though it has real limitations. Enlarged lymph nodes can swell from infection or inflammation rather than cancer. And normal-sized lymph nodes can still harbor cancer cells. That’s why a physical exam alone is never enough to confirm or rule out a diagnosis. It tells the vet where to look next.
Fine Needle Aspirate: The First Tissue Test
When a suspicious lump is found, the most common next step is a fine needle aspirate (FNA). Your vet inserts a thin needle into the mass, draws out a small sample of cells, and sends them to a pathologist for examination under a microscope. The procedure takes seconds, rarely requires sedation, and gives results relatively quickly.
FNA works well for many tumor types. It’s particularly useful for identifying lymphoma, mast cell tumors, and some carcinomas. However, it has meaningful limitations. Because it collects individual cells rather than a structured slice of tissue, it can’t show how cells are arranged within the mass. For liver lesions, one study found that cytology from needle aspirates agreed with the final surgical biopsy diagnosis in only 30% of dogs. Tumors in other organs tend to have higher accuracy, but the takeaway is the same: a needle aspirate can often tell you something is suspicious, but a biopsy is frequently needed to confirm the diagnosis and determine the tumor grade.
Biopsy: The Definitive Answer
A biopsy removes a larger piece of tissue (or sometimes the entire mass) and preserves its architecture so a pathologist can examine cell patterns, margins, and how deeply the tumor invades surrounding tissue. This is the gold standard for cancer diagnosis. It confirms the tumor type and provides a grade, which indicates how aggressive the cancer is likely to behave.
Biopsies typically require sedation or general anesthesia. The tissue sample goes to a diagnostic lab for histopathology, with results usually available in two to four days. Lab fees for histopathology start around $70 for a single site, with additional sites from the same animal costing less. Your veterinary clinic will charge separately for the procedure itself, anesthesia, and any follow-up care.
The biopsy report tells your vet not just whether the mass is cancerous, but what kind of cancer it is and how likely it is to spread. This information drives every treatment decision that follows.
Blood Work and What It Reveals
Blood tests don’t diagnose most cancers directly, but they can raise red flags and reveal how the disease is affecting your dog’s body. A complete blood count and chemistry panel are standard parts of the workup.
High blood calcium is one of the most recognized cancer-associated findings in dogs and is commonly linked to lymphoma and certain anal gland tumors. Unusually low blood sugar can point to a pancreatic tumor called an insulinoma. Elevated pancreatic enzymes may suggest pancreatic inflammation or cancer. Abnormal white blood cell counts, especially the presence of immature cells called blasts in the bloodstream, can indicate leukemia or bone marrow involvement.
These findings aren’t cancer-specific on their own. Infections, organ disease, and other conditions can produce similar results. But when combined with physical exam findings and imaging, blood work helps your vet narrow the possibilities and decide which tests to pursue next.
Imaging: X-rays, Ultrasound, CT, and MRI
Imaging serves two purposes: finding tumors that can’t be felt from the outside, and determining how far a known cancer has spread.
X-rays are usually the first imaging tool. Chest X-rays check for lung metastasis, which is one of the most common places cancers spread in dogs. Bone X-rays can reveal the destructive bone lesions typical of osteosarcoma.
Ultrasound is the go-to tool for evaluating the abdominal cavity. It shows the size, shape, and internal structure of organs and tumors in real time. It also plays a practical role beyond just looking: ultrasound can guide a needle directly into an internal mass for a targeted aspirate or biopsy, making it possible to sample tumors in the spleen, liver, or other organs without surgery.
CT scans provide more anatomical detail than standard X-rays and are especially useful for complex areas like the nasal cavity, brain, and lungs. When radiation therapy is being considered, a CT scan is required to map the exact size and location of the tumor. MRI excels at imaging soft tissue structures and gives the most detailed views of the brain and spinal cord, making it the preferred choice for suspected neurological tumors.
Both CT and MRI require general anesthesia because the dog must remain completely still during the scan. These are typically performed at specialty or university veterinary hospitals rather than general practices.
Bone Marrow Aspirate
For certain cancers, your vet may recommend a bone marrow aspirate. This involves collecting a small sample from inside a bone (usually the hip) to examine the cells being produced there. It’s not part of every cancer workup, but it’s indicated in specific situations: staging lymphoma or mast cell tumors to check for bone marrow involvement, confirming multiple myeloma, investigating unexplained abnormalities on blood work like circulating blast cells, or evaluating for cancers that infiltrate the marrow such as histiocytic sarcoma.
Staging: Mapping How Far Cancer Has Spread
Once a cancer is confirmed, staging determines its extent. Veterinary oncology uses a system similar to human medicine, evaluating three factors: the size of the primary tumor (T), whether nearby lymph nodes are involved (N), and whether the cancer has spread to distant sites (M).
For canine mammary tumors, as one example, staging breaks down like this: Stage I tumors are under 3 cm with no spread. Stage II tumors are 3 to 5 cm, still localized. Stage III tumors exceed 5 cm but haven’t reached the lymph nodes. Stage IV means lymph node involvement regardless of tumor size. Stage V means the cancer has metastasized to distant organs. Each cancer type has its own staging criteria, but the general framework is consistent. Higher stages generally mean more aggressive treatment and a less favorable prognosis.
Staging typically combines several tests already described: imaging (chest X-rays, abdominal ultrasound, possibly CT), lymph node aspirates, and blood work. The goal is to give your veterinarian and any consulting oncologist a complete map of the disease before recommending a treatment plan.
Liquid Biopsy: A Newer Screening Option
A blood-based screening test is now available that detects cancer-associated DNA fragments circulating in the bloodstream. Validated in a study of over 1,000 dogs, the test has a 98.5% specificity, meaning false positives are rare. Its sensitivity, the ability to catch cancers that are actually present, varies significantly by cancer type and stage.
For the three most aggressive canine cancers (lymphoma, hemangiosarcoma, and osteosarcoma), the detection rate is 85.4%. Across eight of the most common canine cancers, it drops to 61.9%. And for early-stage, smaller tumors (localized disease under 5 cm), the detection rate is only about 20%. For large, metastatic tumors it reaches 87.5%, though those cancers are often already causing visible symptoms.
This means the test works best as an additional screening layer, particularly for breeds at high risk for aggressive cancers. A negative result doesn’t rule out cancer, especially early-stage disease. A positive result still requires follow-up with traditional diagnostics like imaging and biopsy to identify the tumor type and location.
Monitoring With Blood Biomarkers
For dogs already diagnosed with cancer, particularly lymphoma, a blood marker called thymidine kinase 1 (TK1) can help track how well treatment is working. In healthy dogs, TK1 activity stays at or below 20 units per liter. Dogs with active lymphoma typically show elevated levels, and those levels drop when treatment is effective.
TK1 is especially useful for distinguishing complete from partial treatment responses, with 100% specificity at certain thresholds, and for catching relapses before clinical signs reappear. A rapid rise in TK1 between checkups predicted relapse at the next visit with about 88% to 94% specificity, giving veterinarians an early warning to adjust treatment. This type of monitoring is typically managed by a veterinary oncologist as part of an ongoing treatment protocol.